Patten & Patten’s DexCom DXCM Stock Holding History

Patten & Patten’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.81M	Sell	60,615 -3,737	-6%	-$260K	0.23%	90
2025 Q4	$4.27M	Sell	64,352 -18,399	-22%	-$1.19M	0.25%	84
2025 Q3	$5.57M	Buy	82,751 +13	+0%	+$1.03K	0.33%	75
2025 Q2	$7.22M	Buy	82,738 +4,780	+6%	+$375K	0.47%	59
2025 Q1	$5.32M	Buy	77,958 +3,147	+4%	+$257K	0.36%	61
2024 Q4	$5.82M	Buy	74,811 +3,570	+5%	+$264K	0.38%	62
2024 Q3	$4.78M	Buy	71,241 +23,568	+49%	+$1.94M	0.32%	67
2024 Q2	$5.41M	Sell	47,673 -686	-1%	-$86.7K	0.38%	58
2024 Q1	$6.71M	Buy	48,359 +2,237	+5%	+$281K	0.48%	54
2023 Q4	$5.72M	Buy	46,122 +825	+2%	+$84.3K	0.47%	53
2023 Q3	$4.23M	Sell	45,297 -1,262	-3%	-$142K	0.37%	61
2023 Q2	$5.98M	Sell	46,559 -950	-2%	-$115K	0.49%	56
2023 Q1	$5.52M	Sell	47,509 -100	-0.2%	-$11.2K	0.49%	57
2022 Q4	$5.39M	Sell	47,609 -920	-2%	-$101K	0.49%	55
2022 Q3	$3.91M	Buy	48,529 +1,373	+3%	+$116K	0.37%	72
2022 Q2	$3.52M	Sell	47,156 -180	-0.4%	-$16.4K	0.31%	74
2022 Q1	$6.05M	Buy	47,336 +1,232	+3%	+$135K	0.44%	65
2021 Q4	$6.19M	Sell	46,104 -1,380	-3%	-$198K	0.43%	70
2021 Q3	$6.49M	Sell	47,484 -916	-2%	-$116K	0.49%	57
2021 Q2	$5.17M	Sell	48,400 -740	-2%	-$71.1K	0.39%	69
2021 Q1	$4.42M	Sell	49,140 -640	-1%	-$60.1K	0.36%	73
2020 Q4	$4.6M	Hold	49,780	–	–	0.4%	65
2020 Q3	$5.13M	Sell	49,780 -1,300	-3%	-$136K	0.51%	55
2020 Q2	$5.18M	Sell	51,080 -4,352	-8%	-$389K	0.57%	48
2020 Q1	$3.73M	Sell	55,432 -220	-0.4%	-$13.7K	0.49%	50
2019 Q4	$3.04M	Sell	55,652 -1,100	-2%	-$52.2K	0.31%	78
2019 Q3	$2.12M	Buy	56,752 +1,920	+4%	+$74.6K	0.23%	87
2019 Q2	$2.05M	Buy	54,832 +8,140	+17%	+$256K	0.22%	90
2019 Q1	$1.39M	Sell	46,692 -4,560	-9%	-$160K	0.15%	105
2018 Q4	$1.53M	Sell	51,252 -28,828	-36%	-$914K	0.19%	96
2018 Q3	$2.86M	Sell	80,080 -14,020	-15%	-$435K	0.28%	84
2018 Q2	$2.23M	Buy	94,100 +9,200	+11%	+$195K	0.23%	96
2018 Q1	$1.57M	Buy	84,900 +4,700	+6%	+$69.5K	0.16%	105
2017 Q4	$1.15M	Sell	80,200 -119,420	-60%	-$1.55M	0.12%	125
2017 Q3	$2.44M	Buy	199,620 +16,140	+9%	+$285K	0.26%	88
2017 Q2	$3.35M	Sell	183,480 -2,200	-1%	-$40.6K	0.37%	68
2017 Q1	$3.93M	Buy	185,680 +12,200	+7%	+$238K	0.45%	63
2016 Q4	$2.59M	Sell	173,480 -25,620	-13%	-$454K	0.32%	76
2016 Q3	$4.36M	Sell	199,100 -2,600	-1%	-$57.9K	0.56%	56
2016 Q2	$4M	Buy	201,700 +7,100	+4%	+$121K	0.55%	60
2016 Q1	$3.3M	Buy	194,600 +101,600	+109%	+$1.7M	0.47%	64
2015 Q4	$1.9M	Buy	93,000 +49,200	+112%	+$1.02M	0.26%	82
2015 Q3	$940K	Buy	43,800 +3,600	+9%	+$80.3K	0.14%	106
2015 Q2	$804K	Buy	40,200 +2,860	+8%	+$50.2K	0.12%	125
2015 Q1	$582K	Buy	+37,340	New	+$564K	0.08%	149

Other funds holding DXCM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Patten & Patten's DXCM Position: Q1 2026 in Review

Patten & Patten reduced its DexCom (DXCM) stake by 5.8% in Q1 2026, selling an estimated $260K and leaving 60,615 shares worth $3.81M. The position accounts for 0.23% of the portfolio, ranked #90.

Patten & Patten first reported a position in DXCM in Q1 2015 and has held it in 45 quarters since. The position peaked at $7.22M in Q2 2025. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

Patten & Patten held 60,615 shares of DexCom worth $3.81M as of Q1 2026.
Patten & Patten sold 3,737 DexCom shares in Q1 2026, an estimated $260K.
DexCom made up 0.23% of Patten & Patten's portfolio in Q1 2026, its #90 holding.
Patten & Patten first reported a position in DexCom in Q1 2015 and has held it in 45 quarters since.
Patten & Patten's DexCom position peaked at $7.22M in Q2 2025.
956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Patten & Patten's 13F filing for Q1 2026, filed 1 May 2026.